US Stock MarketDetailed Quotes

Vertex Pharmaceuticals (VRTX)

Watchlist
  • 430.290
  • -4.810-1.11%
Close Apr 24 16:00 ET
  • 430.290
  • 0.0000.00%
Post 20:01 ET
109.45BMarket Cap28.09P/E (TTM)

Vertex Pharmaceuticals (VRTX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
837.19%3.63B
-14.81%498M
-9.37%1.24B
128.59%1.07B
-37.33%818.9M
-113.93%-492.6M
149.19%584.6M
7.99%1.37B
-430.89%-3.75B
45.19%1.31B
Net income from continuing operations
838.09%3.95B
30.46%1.19B
3.59%1.08B
128.74%1.03B
-41.22%646.3M
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
57.13%1.1B
Operating gains losses
----
----
-75.93%2.6M
-142.52%-5.4M
-44.44%15M
9,516.67%57.7M
1,700.00%7.2M
74.19%10.8M
3,075.00%12.7M
521.88%27M
Depreciation and amortization
1.25%209.8M
19.78%55.7M
1.50%54M
-4.26%51.7M
-9.53%48.4M
14.29%207.2M
-21.19%46.5M
26.37%53.2M
30.43%54M
37.89%53.5M
Deferred tax
-46.44%-510.8M
-40.89%30.5M
-91.32%-235.9M
4.21%-113.8M
-21.04%-191.6M
34.99%-348.8M
139.39%51.6M
-6.75%-123.3M
32.73%-118.8M
-39.59%-158.3M
Other non cash items
12,500.00%113.4M
40.85%23.1M
-116.11%-6.7M
451.69%72.8M
166.48%24.2M
102.11%900K
151.74%16.4M
313.33%41.6M
-84.82%-20.7M
-283.84%-36.4M
Change In working capital
-132.93%-1.2B
-69.19%-947.8M
-5.02%149.6M
45.15%-132.4M
-307.66%-268.5M
-93.75%-514.8M
33.22%-560.2M
-16.62%157.5M
-198.37%-241.4M
-6.91%129.3M
-Change in receivables
-249.75%-347.3M
-244.06%-99.4M
-15.64%-59.9M
-113.62%-18.4M
32.59%-169.6M
-18.07%-99.3M
348.05%69M
-749.18%-51.8M
4,758.62%135.1M
-178.01%-251.6M
-Change in inventory
-1.33%-524.2M
47.53%-77.4M
28.16%-131.1M
-38.62%-148.6M
-108.61%-167.1M
-60.20%-517.3M
-110.71%-147.5M
-87.18%-182.5M
-47.25%-107.2M
3.03%-80.1M
-Change in prepaid assets
-97.70%-396M
-52.25%-250.6M
-294.76%-40.9M
50.99%-76.4M
-128.33%-28.1M
63.29%-200.3M
63.53%-164.6M
117.36%21M
-695.41%-155.9M
114.72%99.2M
-Change in payables and accrued expense
-130.53%-80.1M
-100.90%-626.2M
25.73%297.6M
21.65%174.2M
-61.74%74.3M
-45.12%262.4M
19.77%-311.7M
-37.36%236.7M
-54.15%143.2M
10.09%194.2M
-Change in other current liabilities
274.06%148.5M
2,059.26%105.8M
-37.43%83.9M
75.37%-63.2M
-86.87%22M
-81.00%39.7M
-109.73%-5.4M
276.69%134.1M
-1,003.52%-256.6M
87.47%167.6M
Cash from discontinued investing activities
Operating cash flow
837.19%3.63B
-14.81%498M
-9.37%1.24B
128.59%1.07B
-37.33%818.9M
-113.93%-492.6M
149.19%584.6M
7.99%1.37B
-430.89%-3.75B
45.19%1.31B
Investing cash flow
Cash flow from continuing investing activities
74.92%-945.4M
64.95%-288.1M
66.38%-117M
-4.49%-484.5M
97.39%-55.8M
-20.00%-3.77B
7.29%-821.9M
-195.67%-348M
-52.58%-463.7M
-16.51%-2.14B
Net PPE purchase and sale
-46.99%-437.6M
-61.34%-149.4M
-50.37%-101.8M
-111.16%-145.7M
40.50%-40.7M
-48.55%-297.7M
-59.38%-92.6M
-66.75%-67.7M
-15.77%-69M
-62.47%-68.4M
Net intangibles purchase and sale
--0
--0
--0
--0
--0
-223.62%-187.7M
--0
--0
---7.7M
---180M
Net business purchase and sale
----
----
----
----
----
--0
--258M
----
----
----
Net investment purchase and sale
85.05%-483.1M
87.16%-122.8M
-12.68%-16M
10.08%-334.5M
99.48%-9.8M
-13.26%-3.23B
-24.14%-956.4M
81.32%-14.2M
-73.51%-372M
-5.39%-1.89B
Net other investing changes
54.26%-24.7M
48.54%-15.9M
109.88%800K
---4.3M
---5.3M
-74.19%-54M
---30.9M
-636.36%-8.1M
----
----
Cash from discontinued investing activities
Investing cash flow
74.92%-945.4M
64.95%-288.1M
66.38%-117M
-4.49%-484.5M
97.39%-55.8M
-20.00%-3.77B
7.29%-821.9M
-195.67%-348M
-52.58%-463.7M
-16.51%-2.14B
Financing cash flow
Cash flow from continuing financing activities
-51.27%-2.26B
80.27%-77.2M
-197.94%-1.15B
2.62%-349.2M
-90.32%-680.4M
-165.90%-1.49B
-226.63%-391.3M
-134.85%-387.5M
-2,172.83%-358.6M
-21.31%-357.5M
Net issuance payments of debt
83.93%-5.4M
-7.69%-1.4M
74.07%-1.4M
90.51%-1.3M
90.15%-1.3M
25.17%-33.6M
89.17%-1.3M
52.21%-5.4M
-24.55%-13.7M
-24.53%-13.2M
Net common stock issuance
-50.89%-2.39B
69.21%-130.9M
-196.91%-1.16B
0.77%-397.7M
-91.01%-696.6M
-142.02%-1.58B
-178.45%-425.2M
-129.96%-391.4M
-1,176.43%-400.8M
-21.81%-364.7M
Proceeds from stock option exercised by employees
11.43%127.7M
57.43%54M
-5.95%7.9M
-10.73%49.1M
-1.18%16.7M
-14.86%114.6M
-26.08%34.3M
-45.45%8.4M
-6.14%55M
19.01%16.9M
Net other financing activities
-40.32%3.7M
22.22%1.1M
22.22%1.1M
-22.22%700K
-77.14%800K
244.44%6.2M
160.00%900K
-18.18%900K
-18.18%900K
218.18%3.5M
Cash from discontinued financing activities
Financing cash flow
-51.27%-2.26B
80.27%-77.2M
-197.94%-1.15B
2.62%-349.2M
-90.32%-680.4M
-165.90%-1.49B
-226.63%-391.3M
-134.85%-387.5M
-2,172.83%-358.6M
-21.31%-357.5M
Net cash flow
Beginning cash position
-55.92%4.57B
-5.72%4.95B
8.52%4.98B
-48.90%4.69B
-55.92%4.57B
-1.33%10.37B
-52.79%5.25B
-54.78%4.59B
-1.36%9.17B
-1.33%10.37B
Current changes in cash
107.38%424.7M
121.11%132.7M
-104.75%-30.1M
105.23%239.4M
106.97%82.7M
-3,355.88%-5.76B
18.54%-628.6M
-35.65%634.3M
-639.74%-4.58B
3.35%-1.19B
Effect of exchange rate changes
313.38%90.9M
115.43%7.3M
-117.98%-4.1M
2,388.00%57.2M
295.51%30.5M
-258.36%-42.6M
-272.63%-47.3M
201.33%22.8M
-125.00%-2.5M
-230.00%-15.6M
End cash Position
11.28%5.09B
11.28%5.09B
-5.72%4.95B
8.52%4.98B
-48.90%4.69B
-55.92%4.57B
-55.92%4.57B
-52.79%5.25B
-54.78%4.59B
-1.36%9.17B
Free cash flow
426.56%3.19B
-29.15%348.6M
-12.48%1.14B
124.21%927.4M
-26.46%778.2M
-129.83%-978M
315.19%492M
6.05%1.3B
-456.37%-3.83B
23.36%1.06B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 837.19%3.63B-14.81%498M-9.37%1.24B128.59%1.07B-37.33%818.9M-113.93%-492.6M149.19%584.6M7.99%1.37B-430.89%-3.75B45.19%1.31B
Net income from continuing operations 838.09%3.95B30.46%1.19B3.59%1.08B128.74%1.03B-41.22%646.3M-114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B57.13%1.1B
Operating gains losses ---------75.93%2.6M-142.52%-5.4M-44.44%15M9,516.67%57.7M1,700.00%7.2M74.19%10.8M3,075.00%12.7M521.88%27M
Depreciation and amortization 1.25%209.8M19.78%55.7M1.50%54M-4.26%51.7M-9.53%48.4M14.29%207.2M-21.19%46.5M26.37%53.2M30.43%54M37.89%53.5M
Deferred tax -46.44%-510.8M-40.89%30.5M-91.32%-235.9M4.21%-113.8M-21.04%-191.6M34.99%-348.8M139.39%51.6M-6.75%-123.3M32.73%-118.8M-39.59%-158.3M
Other non cash items 12,500.00%113.4M40.85%23.1M-116.11%-6.7M451.69%72.8M166.48%24.2M102.11%900K151.74%16.4M313.33%41.6M-84.82%-20.7M-283.84%-36.4M
Change In working capital -132.93%-1.2B-69.19%-947.8M-5.02%149.6M45.15%-132.4M-307.66%-268.5M-93.75%-514.8M33.22%-560.2M-16.62%157.5M-198.37%-241.4M-6.91%129.3M
-Change in receivables -249.75%-347.3M-244.06%-99.4M-15.64%-59.9M-113.62%-18.4M32.59%-169.6M-18.07%-99.3M348.05%69M-749.18%-51.8M4,758.62%135.1M-178.01%-251.6M
-Change in inventory -1.33%-524.2M47.53%-77.4M28.16%-131.1M-38.62%-148.6M-108.61%-167.1M-60.20%-517.3M-110.71%-147.5M-87.18%-182.5M-47.25%-107.2M3.03%-80.1M
-Change in prepaid assets -97.70%-396M-52.25%-250.6M-294.76%-40.9M50.99%-76.4M-128.33%-28.1M63.29%-200.3M63.53%-164.6M117.36%21M-695.41%-155.9M114.72%99.2M
-Change in payables and accrued expense -130.53%-80.1M-100.90%-626.2M25.73%297.6M21.65%174.2M-61.74%74.3M-45.12%262.4M19.77%-311.7M-37.36%236.7M-54.15%143.2M10.09%194.2M
-Change in other current liabilities 274.06%148.5M2,059.26%105.8M-37.43%83.9M75.37%-63.2M-86.87%22M-81.00%39.7M-109.73%-5.4M276.69%134.1M-1,003.52%-256.6M87.47%167.6M
Cash from discontinued investing activities
Operating cash flow 837.19%3.63B-14.81%498M-9.37%1.24B128.59%1.07B-37.33%818.9M-113.93%-492.6M149.19%584.6M7.99%1.37B-430.89%-3.75B45.19%1.31B
Investing cash flow
Cash flow from continuing investing activities 74.92%-945.4M64.95%-288.1M66.38%-117M-4.49%-484.5M97.39%-55.8M-20.00%-3.77B7.29%-821.9M-195.67%-348M-52.58%-463.7M-16.51%-2.14B
Net PPE purchase and sale -46.99%-437.6M-61.34%-149.4M-50.37%-101.8M-111.16%-145.7M40.50%-40.7M-48.55%-297.7M-59.38%-92.6M-66.75%-67.7M-15.77%-69M-62.47%-68.4M
Net intangibles purchase and sale --0--0--0--0--0-223.62%-187.7M--0--0---7.7M---180M
Net business purchase and sale ----------------------0--258M------------
Net investment purchase and sale 85.05%-483.1M87.16%-122.8M-12.68%-16M10.08%-334.5M99.48%-9.8M-13.26%-3.23B-24.14%-956.4M81.32%-14.2M-73.51%-372M-5.39%-1.89B
Net other investing changes 54.26%-24.7M48.54%-15.9M109.88%800K---4.3M---5.3M-74.19%-54M---30.9M-636.36%-8.1M--------
Cash from discontinued investing activities
Investing cash flow 74.92%-945.4M64.95%-288.1M66.38%-117M-4.49%-484.5M97.39%-55.8M-20.00%-3.77B7.29%-821.9M-195.67%-348M-52.58%-463.7M-16.51%-2.14B
Financing cash flow
Cash flow from continuing financing activities -51.27%-2.26B80.27%-77.2M-197.94%-1.15B2.62%-349.2M-90.32%-680.4M-165.90%-1.49B-226.63%-391.3M-134.85%-387.5M-2,172.83%-358.6M-21.31%-357.5M
Net issuance payments of debt 83.93%-5.4M-7.69%-1.4M74.07%-1.4M90.51%-1.3M90.15%-1.3M25.17%-33.6M89.17%-1.3M52.21%-5.4M-24.55%-13.7M-24.53%-13.2M
Net common stock issuance -50.89%-2.39B69.21%-130.9M-196.91%-1.16B0.77%-397.7M-91.01%-696.6M-142.02%-1.58B-178.45%-425.2M-129.96%-391.4M-1,176.43%-400.8M-21.81%-364.7M
Proceeds from stock option exercised by employees 11.43%127.7M57.43%54M-5.95%7.9M-10.73%49.1M-1.18%16.7M-14.86%114.6M-26.08%34.3M-45.45%8.4M-6.14%55M19.01%16.9M
Net other financing activities -40.32%3.7M22.22%1.1M22.22%1.1M-22.22%700K-77.14%800K244.44%6.2M160.00%900K-18.18%900K-18.18%900K218.18%3.5M
Cash from discontinued financing activities
Financing cash flow -51.27%-2.26B80.27%-77.2M-197.94%-1.15B2.62%-349.2M-90.32%-680.4M-165.90%-1.49B-226.63%-391.3M-134.85%-387.5M-2,172.83%-358.6M-21.31%-357.5M
Net cash flow
Beginning cash position -55.92%4.57B-5.72%4.95B8.52%4.98B-48.90%4.69B-55.92%4.57B-1.33%10.37B-52.79%5.25B-54.78%4.59B-1.36%9.17B-1.33%10.37B
Current changes in cash 107.38%424.7M121.11%132.7M-104.75%-30.1M105.23%239.4M106.97%82.7M-3,355.88%-5.76B18.54%-628.6M-35.65%634.3M-639.74%-4.58B3.35%-1.19B
Effect of exchange rate changes 313.38%90.9M115.43%7.3M-117.98%-4.1M2,388.00%57.2M295.51%30.5M-258.36%-42.6M-272.63%-47.3M201.33%22.8M-125.00%-2.5M-230.00%-15.6M
End cash Position 11.28%5.09B11.28%5.09B-5.72%4.95B8.52%4.98B-48.90%4.69B-55.92%4.57B-55.92%4.57B-52.79%5.25B-54.78%4.59B-1.36%9.17B
Free cash flow 426.56%3.19B-29.15%348.6M-12.48%1.14B124.21%927.4M-26.46%778.2M-129.83%-978M315.19%492M6.05%1.3B-456.37%-3.83B23.36%1.06B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More